Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENA-001 in Preventing Postoperative Respiratory Depression
NCT06137638Phase 2Not yet recruiting
- Sponsor
- Enalare Therapeutics
- Start
- Dec 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ENA-001 in respiratory depression, sponsored by Enalare Therapeutics. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
ENA-001
03
Conditions
respiratory depression
Beyond the preview
Go deeper on NCT06137638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06137638.